- 首頁
- App 分析
- Research To Practice
- Research To Practice Vs. Tempus Provider
Research To Practice 與 Tempus Provider 使用情況與統計
Research To Practice’s CME/CNE accredited activities provide comprehensive perspectives on emerging cancer research and practical management strategies for practicing oncology clinicians. Featuring audio, video and slide-based formats edited by Dr Neil Love, RTP’s programs bridge the gap between clinical research and patient care.
Key Features:
- Sort educational activities by recent releases or by tumor type
- View “Dr Love’s Picks”
- Listen to audio or read text excerpts*
- Watch webcasts, symposia proceedings and investigator presentations
- Review slide sets
- View upcoming events moderated by Dr Love
- CME and CNE accredited
- All content is free
* Text not available on all programs
- Apple App Store
- 免費版
- 醫療
商店排名
- -
The Tempus mobile app gives oncology providers fast and reliable access to patient reports, advanced patient search, and real-time order tracking.
View interactive and in-depth patient results with:
- Next-generation sequencing results including genomic variants and immunotherapy markers
- Sortable and filterable clinical decision support tools including treatment implications and clinical trial(s) matched to patient's clinical and molecular profile
- Comprehensive gene descriptions paired with matched therapies
- Quick access to your patient’s structured clinical timeline
- PDF of your full Tempus report all within the app
- Access your patient's data quickly and securely with Touch ID or Face ID
- Instantly know when a new report is available via push notifications
- Check the status of an order from receipt of specimens through sequencing and report delivery
- Apple App Store
- 免費版
- 醫療
商店排名
- -
Research To Practice與 Tempus Provider 比較排名
比較過去 28 天的 Research To Practice 排名趨勢與 Tempus Provider
排名
無可用數據
各國 Research To Practice vs. Tempus Provider 排名比較
比較過去 28 天的 Research To Practice 排名趨勢與 Tempus Provider
無可顯示數據
使用我們的免費試用版,與所有網站進行比較
Research To Practice VS.
Tempus Provider
12月 17, 2024